A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 73,427 shares of AUPH stock, worth $650,563. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,427
Previous 68,334 7.45%
Holding current value
$650,563
Previous $390,000 37.95%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.32 - $7.33 $27,094 - $37,331
5,093 Added 7.45%
73,427 $538,000
Q2 2024

Aug 14, 2024

BUY
$4.81 - $5.78 $328,686 - $394,970
68,334 New
68,334 $390,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.26B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.